Litigation Details for Genus Lifesciences Inc. v. Lannett Company, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Genus Lifesciences Inc. v. Lannett Company, Inc. (D. Del. 2020)
| Docket | ⤷ Start Trial | Date Filed | 2020-06-08 |
| Court | District Court, D. Delaware | Date Terminated | 2021-10-20 |
| Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Parties | LANNETT COMPANY, INC. | ||
| Patents | 10,016,407; 10,149,843; 10,231,961; 10,413,505; 10,420,760; 10,857,095; 10,894,012; 10,933,060; 9,867,815 | ||
| Attorneys | Blake B. Greene | ||
| Firms | K & L Gates, LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Genus Lifesciences Inc. v. Lannett Company, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial and ⤷ Start Trial .
Details for Genus Lifesciences Inc. v. Lannett Company, Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-06-08 | External link to document | |||
| 2020-06-08 | 1 | Complaint | This is an action for patent infringement of U.S. Patent Nos. 9,867,815; 10,016,407; and 10,420,760 (collectively…. 15. United States Patent No. 10,016,407 (the “’407 patent”), titled “Pharmaceutical Compositions… THE PATENTS-IN-SUIT 12. United States Patent No. 9,867,815 (the “’815 patent”), titled…collectively, “the Patents-in-Suit”) under the patent laws of the United States, Title 35, United States…1338 because this is a patent infringement action that arises under the patent laws of the United States | External link to document |
| 2020-06-08 | 14 | Declaration | –18 of U.S. Patent No. 9,867,815; and claims 2–5 and 12–15 of U.S. Patent No. 10,016,407 arising from…2020 20 October 2021 1:20-cv-00770 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2020-06-08 | 28 | Brief - Reply | 10,016,407 (“the ’407 patent”); and claims 1, 4, 7–12, 15, and 18–20 of U.S. Patent No. 10,420,760 (“… U.S. Patent No. 9,867,815 (“the ’815 patent”); claims 1, 6, 9-11, 16, 19, and 20 of U.S. Patent No. 10,016,407…of the ’815 patent and claims 2–5, and 12–15 of the ’407 patent, (2) the Unasserted Patents, and (3) C-Topical…Genus sued Lannett for patent infringement on specific claims of three patents.1 In response, Lannett …(“the ’760 patent”) (collectively, “the Asserted Patents” and “the Asserted Claims”). 2 Lannett’s Memorandum | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
